Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

S&P 500 Slides as Tech Rally Fizzles

Published 01/14/2022, 05:10 AM
Updated 01/14/2022, 05:10 AM
© Reuters.

By Yasin Ebrahim

Investing.com – The S&P 500 closed lower Thursday, as selling in tech stocks resumed following a rebound earlier this week. 

The S&P 500 fell 1.4%, the Dow Jones Industrial Average slipped 0.5%, or 174 points, the Nasdaq lost 2.5%.

Meta, formerly Facebook (NASDAQ:FB), Google-parent Alphabet (NASDAQ:GOOGL), Amazon (NASDAQ:AMZN),  Apple (NASDAQ:AAPL), and Microsoft (NASDAQ:MSFT) were in the red, with the latter down more than 4%.

Still, some on Wall Street see growth ahead for Microsoft as strong cloud spending by businesses will likely benefit the company’s cloud business Azure.

“Our December quarter checks for Microsoft have shown incremental strength again as the Azure cloud growth story is hitting its next gear of growth in Redmond,” Wedbush said.

The stock is set to climb over the next six to nine months “despite multiple/valuation compression and a tightening Fed backdrop […] as the Street is still underestimating the underlying growth story in Redmond (Microsoft),” it added.

Snap (NYSE:SNAP), meanwhile, slumped 10% after Cowen downgraded the stock to market perform, citing ongoing challenges from Apple’s change in privacy rules.

The slowdown in rising Treasury yields rates following data showing inflation pressures for businesses slowed in December didn’t offer any respite for tech.

The PPI rose 0.2% in December, well below the 0.4% rise expected and slower than the 1.0% gain seen in November.

On the labor market front, meanwhile weekly jobless claims unexpectedly rose by 23,000, with economists citing the impact of the Omicron variant.

The Omicron disruptions, however, are expected to be “short-lived, but they will create some volatility in the next couple of weeks,” Jefferies said in a note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Health care was also a drag on the broader market, paced by a more than 5% slump in Moderna (NASDAQ:MRNA) even as the company said it expected to report data from its Covid-19 vaccine trials in pediatric cohorts aged 2- to 5-year-olds in March.

Elsewhere on the pandemic front, the Supreme Court blocked President Joe Biden’s vaccine-or-test rule, which would require that businesses with at least 100 employees mandate vaccinations or test weekly for Covid.

Industrials ended the day higher, outperforming the broader market, underpinned by a rally in airline stocks following a better-than-expected quarterly results from Delta Air Lines as travel demand continued to improve.

American Airlines (NASDAQ:AAL) jumped 4%, United Airlines were up 3%, while Delta Air Lines (NYSE:DAL) was up more than 1%.

Consumer staples and utilities defensive concerns of the market were also in ascendency as investors sought safety. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.